Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001448788-19-000026
Filing Date
2019-12-16
Accepted
2019-12-16 17:00:31
Documents
95
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 SUNWIN STEVIA INTERNATIONAL, INC. FORM 10-Q suwn10-q.htm 10-Q 944494
2 SECTION 302 CERTIFICATE OF CHIEF EXECUTIVE OFFICER exh31-1.htm EX-31.1 7670
3 SECTION 302 CERTIFICATE OF CHIEF FINANCIAL OFFICER exh31-2.htm EX-31.2 7675
4 SECTION 906 CERTIFICATE OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER exh32-1.htm EX-32.1 5300
  Complete submission text file 0001448788-19-000026.txt   3751114

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT suwn-20191031.xml EX-101.INS 619223
6 XBRL TAXONOMY EXTENSION SCHEMA suwn-20191031.xsd EX-101.SCH 81338
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE suwn-20191031_cal.xml EX-101.CAL 25191
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE suwn-20191031_def.xml EX-101.DEF 37609
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE suwn-20191031_lab.xml EX-101.LAB 261172
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE suwn-20191031_pre.xml EX-101.PRE 197539
Mailing Address 6 SHENGWANG AVENUE, QUFU, SHANDONG F4 273100
Business Address 6 SHENGWANG AVENUE, QUFU, SHANDONG F4 273100 (86) 537-4424999
SUNWIN STEVIA INTERNATIONAL, INC. (Filer) CIK: 0000806592 (see all company filings)

EIN.: 562416925 | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-53595 | Film No.: 191287905
SIC: 2834 Pharmaceutical Preparations